Thomasville National Bank Grows Stake in Cardinal Health, Inc. $CAH

Thomasville National Bank increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 40.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,976 shares of the company’s stock after purchasing an additional 2,568 shares during the period. Thomasville National Bank’s holdings in Cardinal Health were worth $1,409,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC grew its position in shares of Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after purchasing an additional 75 shares in the last quarter. Vermillion & White Wealth Management Group LLC increased its holdings in shares of Cardinal Health by 55.0% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after purchasing an additional 71 shares during the last quarter. NewSquare Capital LLC lifted its position in shares of Cardinal Health by 100.0% in the second quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after buying an additional 107 shares in the last quarter. Finally, AlphaCore Capital LLC purchased a new stake in Cardinal Health during the second quarter valued at $41,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.9%

CAH opened at $202.80 on Friday. Cardinal Health, Inc. has a 52 week low of $116.03 and a 52 week high of $214.93. The company has a market capitalization of $48.19 billion, a P/E ratio of 30.59, a PEG ratio of 1.48 and a beta of 0.63. The stock’s fifty day moving average is $191.05 and its two-hundred day moving average is $168.28.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter last year, the firm posted $1.88 earnings per share. The business’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is 30.77%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Leerink Partners increased their price target on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a report on Monday, November 17th. Argus lifted their target price on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Barclays assumed coverage on Cardinal Health in a research report on Monday, December 8th. They issued an “overweight” rating and a $243.00 price target for the company. Citigroup lifted their price target on shares of Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. Finally, Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $209.00.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.